Page last updated: 2024-08-24

nelfinavir and nelfinavir mesylate

nelfinavir has been researched along with nelfinavir mesylate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appelt, K; Burgess, JA; Campanale, KM; Chirgadze, NY; Clawson, DK; Davies, JF; Dressman, BA; Fritz, JE; Hatch, SD; Kaldor, SW; Kalish, VJ; Khalil, DA; Kosa, MB; Lubbehusen, PP; Muesing, MA; Patick, AK; Reich, SH; Shetty, BV; Su, KS; Tatlock, JH	1

Other Studies

1 other study(ies) available for nelfinavir and nelfinavir mesylate

Article	Year
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. Journal of medicinal chemistry, 1997, Nov-21, Volume: 40, Issue:24 Topics: Administration, Oral; Animals; Anti-HIV Agents; Biological Availability; Callithrix; Dogs; Dose-Response Relationship, Drug; Female; HIV Protease Inhibitors; HIV-1; Macaca fascicularis; Male; Nelfinavir; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship	1997

Article

Year

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.

Journal of medicinal chemistry, 1997, Nov-21, Volume: 40, Issue:24

Topics: Administration, Oral; Animals; Anti-HIV Agents; Biological Availability; Callithrix; Dogs; Dose-Response Relationship, Drug; Female; HIV Protease Inhibitors; HIV-1; Macaca fascicularis; Male; Nelfinavir; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

1997